IDIANISE VILDOR: Open Payments
NPI 1679060206 · ALTAMONTE SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,118 in 239 payments from 19 companies in 2025. Trend: 2023 $4,072 · 2024 $3,805 · 2025 $4,118
Food & beverage: $4,118
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $552 |
| Neurocrine BioSciences, Inc. | 27 | $547 |
| Vanda Pharmaceuticals Inc. | 14 | $305 |
| Corium, LLC | 15 | $288 |
| Supernus Pharmaceuticals, Inc. | 31 | $273 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $244 |
| Janssen Pharmaceuticals, Inc | 12 | $237 |
| Collegium Pharmaceutical, Inc. | 14 | $235 |
| E.R. Squibb & Sons, L.L.C. | 10 | $234 |
| Axsome Therapeutics, Inc. | 10 | $222 |
Products named: VRAYLAR, INGREZZA, Azstarys, Qelbree, CAPLYTA, Jornay PM, COBENFY, REXULTI.
Industry payments across FL — which companies pay providers there.
